Skip to Main Content

As part of its landmark $18.5 billion deal to buy Livongo, telehealth giant Teladoc Health is poised to inherit a set of devices that the chronic care company has used for years to turn mountains of patient data into easily digestible health advice.

The technology — which includes connected blood pressure cuffs, glucose monitors, and weight scales — will be a key asset for the newly combined company, which will be called Teladoc. Not only does the trove of devices better position Teladoc to deliver chronic care, it also tees up the company to fully enter the remote monitoring space.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!